NOVELION THERAPEUTICS

DEAD

Serial Number

87177217

Owner

Aegerion Pharmaceuticals, Inc.

Attorney

Todd Armstrong

Filing Date

Sep 20, 2016

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

NOVELION THERAPEUTICS Trademark

Serial Number: 87177217

NOVELION THERAPEUTICS is a trademark filed by Aegerion Pharmaceuticals, Inc. on September 20, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Aegerion Pharmaceuticals, Inc. (33 trademarks)

Centerpointe IV, 1140 Route 22 East
Bridgewater, NJ 08807

Entity Type: 03

NOVELION THERAPEUTICS INC. (7 trademarks)

1800 - 510 WEST GEORGIA STREET
VANCOUVER BC V6B 0M , CA

Entity Type: 03

Legal Representation

Attorney of Record

Todd Armstrong

20 trademarks filed View all →

Trademark Details

Filing Date

September 20, 2016

Registration Date

Not Registered

Published for Opposition

August 8, 2017

Goods & Services

Pharmaceutical preparations, namely pharmaceutical preparations for the treatment and prevention of metabolic diseases and disorders, endocrine diseases and disorders, hormonal diseases and disorders, cardiovascular diseases and disorders, reproductive diseases and disorders, and ophthalmic diseases and disorders; medical preparations, namely preparations for the treatment and prevention of metabolic diseases and disorders, endocrine diseases and disorders, hormonal diseases and disorders, cardiovascular diseases and disorders, reproductive diseases and disorders, and ophthalmic diseases and disorders

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Jun 8, 2020 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Jun 8, 2020 ABN6

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 3, 2019 EXRA

SOU EXTENSION 4 GRANTED

Oct 1, 2019 EX4G

SOU EXTENSION 4 FILED

Oct 1, 2019 EXT4

SOU TEAS EXTENSION RECEIVED

Oct 1, 2019 EEXT

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Sep 25, 2019 ASGN

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 29, 2019 EXRA

SOU EXTENSION 3 GRANTED

Mar 27, 2019 EX3G

SOU EXTENSION 3 FILED

Mar 27, 2019 EXT3

SOU TEAS EXTENSION RECEIVED

Mar 27, 2019 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 27, 2018 EXRA

SOU EXTENSION 2 GRANTED

Sep 25, 2018 EX2G

SOU EXTENSION 2 FILED

Sep 25, 2018 EXT2

SOU TEAS EXTENSION RECEIVED

Sep 25, 2018 EEXT

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Apr 18, 2018 ASCK

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 27, 2018 EXRA

SOU EXTENSION 1 GRANTED

Mar 23, 2018 EX1G

SOU EXTENSION 1 FILED

Mar 23, 2018 EXT1

SOU TEAS EXTENSION RECEIVED

Mar 23, 2018 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Oct 3, 2017 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 8, 2017 NPUB

PUBLISHED FOR OPPOSITION

Aug 8, 2017 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 19, 2017 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 28, 2017 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 16, 2017 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 15, 2017 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 15, 2017 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 3, 2017 GNRN

NON-FINAL ACTION E-MAILED

Jan 3, 2017 GNRT

NON-FINAL ACTION WRITTEN

Jan 3, 2017 CNRT

ASSIGNED TO EXAMINER

Dec 27, 2016 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 26, 2016 NWOS

Related Trademarks

More from this Owner

NOVELION THERAPEUTICS

A RARE FOCUS

NOVELION THERAPEUTICS

More in Same Class

FULLSEN

INGELVAC PROVENZA